The 3rd International

Human Gene Therapy
Conference

November 13-14, 2025 | Boston, USA

Supported by

Meet_Boston_Primary_Logo

Key Dates of Gene Forum

March 30, 2024

Abstract Submission Commencement

April 10, 2024

Registration Commencement

September 30, 2024

Abstract Submission Deadline

September 30, 2024

Early-bird Registration Deadline

// Welcome Note

The 3rd International Human Gene Therapy Conference

We are delighted to invite you to participate in the 3rd International Human Gene Therapy Conference 2025, taking place from November 13–14, 2025, in the dynamic and historic city of Boston, USA. This prestigious global event serves as a leading platform for sharing groundbreaking developments in human gene therapy, genome editing, and cell-based therapeutic innovations.

As the field of gene therapy continues to accelerate at an unprecedented pace, this conference brings together the brightest minds in biomedical science, clinical research, biotechnology, pharmaceutical development, and regulatory affairs. Attendees will include world-renowned scientists, renowned clinicians, biotech entrepreneurs, policy makers, and industry stakeholders, all gathered with one mission: to explore how gene therapy is transforming modern medicine.


Explore the Future of Gene and Cell Therapies

Gene therapy holds the promise of treating—and potentially curing—a range of genetic and acquired conditions that were once thought to be incurable. From monogenic disorders such as sickle cell disease and hemophilia to more complex diseases like certain cancers and neurodegenerative conditions, the clinical applications of gene therapy are expanding rapidly.

Co-Chairs

Mitra Tavakkoli
Mitra Tavakkoli

Senior Biotech Consultant
4D Molecular Therapeutics
USA

Arun Srivastava
Arun Srivastava

Professor
University of Florida College of Medicine
USA

sample image
Binh Nguyen

EX-FDA, President
Wynngate Corporation
USA

Jeff Chaffin
Jeff Chaffin

Market Access Strategy and Contracting Consultant
Miles Payer Strategy
USA

Hildegund Ertl
Hildegund Ertl

Professor
The Wistar Institute
USA

Sophie Blondel
Sophie Blondel

Consultant and Cell and Gene
Therapies Expert, France

Invitation to Participate in the 3rd International Human Gene Therapy Conference 2025

We are pleased to invite you to attend the 3rd International Human Gene Therapy Conference 2025, which will take place from November 13–14, 2025, in Boston, USA. This distinguished global event is designed to bring together a diverse and interdisciplinary group of experts, including pioneering scientists, clinical researchers, biotech professionals, early-career investigators, and students from around the world.

The conference serves as a vibrant platform to foster collaboration, exchange knowledge, and showcase the most recent advances in gene therapy, genome editing, and cell-based therapeutics. It aims to highlight the transformative potential of gene therapy in treating genetic and acquired diseases and to explore the clinical, scientific, regulatory, and commercial developments driving the field forward.

Attendees will benefit from an engaging program that includes keynote lectures by internationally recognized leaders, thematic technical sessions, poster presentations, and ample opportunities for professional networking. Topics will span a wide range of areas, including CRISPR and gene editing technologies, viral and non-viral vectors, therapeutic gene delivery, clinical trial outcomes, and ethical and regulatory perspectives.

Featured Speakers

Anne Douar
Anne Douar

Chief Operating Officer, Vivet Therapeutics, France

Binh Nguyen
Binh Nguyen

President, WYNNGATE Corporation, EX-FDA, USA

Cellia Habita
Cellia Habita

Biotech Senior Executive, Expert in Drug Development & Clinical Development Operations, France

James L Drinkwater
James L Drinkwater

Ex-Chairman Honorary Member of PHSS, Head of GMP Compliance, Franz Ziel GmbH, United Kingdom

Jeff Chaffin
Jeff Chaffin

Principal
Miles Payer Consulting, USA

Larry Forman
Larry Forman

Founder & CEO
CHO Plus, USA

Mitra Tavakkoli
Mitra Tavakkoli

Clinical Development Physician and Senior Biotech Consultant, USA

Natasha Paterson
Natasha Paterson

Executive Director Medical Affairs, Tenaya Therapeutics, USA

Olivier Negre
Olivier Negre

Chief Scientific Officer, Smart Immune, France

Sophie Blondel
Sophie Blondel

Consultant and Cell and Gene Therapies Expert, France

Tristan Jervis
Tristan Jervis

Founder and Managing Director, Impact Shine Communications, UK

// SCIENTIFIC SESSION

Key Topics

  • Gene Therapy Development and Methods
  • Gene Drug Delivery and Recent Gene Editing Technologies
  • Gene Therapy R&D Acceleration by AI
  • Gene Therapy Successes and Ongoing Research
  • DNA & RNA based Technologies
  • Gene Therapy Clinical Trials and Patient Engagement
  • Benefits, Risks and Applications of Gene Therapy
  • Gene Therapy Regulatory Landscape
  • Safety, Efficacy, Risk Management and Pharmacovigilance in CGT
  • Ethical and Societal Considerations
  • Worldwide Approved and Successfully Running CGTs
  • Quality Assurance and Quality Control
  • GLP, GMP Compliances
  • Analytical Process Development and Scale-Up Technologies
  • Market Analysis, Trends and Opportunities
  • Logistics, Supply Chain, Cost Optimization and Affordability
  • Pricing Strategies, Market Access, Commercialization and Reimbursement IPR's and Licensing
  • Investments, Partnerships and Fundings on Global Scale
  • Success Stories from Research Lab to Market
  • CGT Approaches for Cancer Treatment
  • Combination of Gene and Cellular Immunotherapies
  • CGT Approaches for HIV-AIDS, Pulmonary Disorders, Sickle Cell Anaemia, Cystic Fibrosis, Alpha-1 Antitrypsin Deficiency, Haemophilia, Beta thalassemia, Diabetes
  • Gene therapy for Ophthalmic and Muscular Disorders
  • Gene Therapy for Neurodegenerative and Rare disorders
  • Bio Revolution Uniting 3D Bioprinting and Gene Therapy for Tomorrow's Healthcare
  • Emerging Therapies for Genetic Disorders
  • Navigating Next by NGS Technology

Keynote Speakers

Terence R flotte
Terence R Flotte

Professor, Provost and Dean
UMass Chan Medical School,
USA

Thierry VandenDriessche
Thierry VandenDriessche

Professor
Vrije Universiteit Brussel
Belgium

Barry J Byrne
Barry J Byrne

Director of the Powell Gene Therapy Center
University of Florida
USA

Barry J Byrne
John Engelhardt

Director
Center for Gene Therapy University of lowa
USA

Claire M. Gelfman, Ph.D.
Claire M. Gelfman

Principal
CMG Consulting
Retina Gene Therapy Focus
USA

Katherine High
Katherine High

Board Member
CRISPR Therapeutics
USA

Chris A. Learn
Chris A. Learn

Senior Vice President
Cell and Gene Therapy Center of Excellence
Parexel International
USA

Andrew Steinsapir
Andrew Steinsapir

Director, Gene Therapy Program Lead
Deerfield Discovery and Development
USA

Supported by

Meet_Boston_Primary_Logo

Why Attend the Gene Therapy Conference

1. Access to Cutting-Edge Research

Stay informed about the latest advancements in gene therapy, including novel gene editing technologies and personalized medicine strategies, directly from leading experts.

2. Expert Keynote Speakers

Gain valuable insights from renowned professionals who will present pioneering research, breakthroughs, and innovative methodologies in gene therapy.

3. Diverse Range of Topics

Participate in a comprehensive program that covers various aspects of gene therapy, including genetic disorders, delivery systems, and regulatory challenges.

4. Interactive Panel Discussions

Engage in dynamic discussions with thought leaders and fellow attendees on complex topics, fostering dialogue and enhancing collaborative problem-solving.

5. Networking Opportunities

Connect with top scientists, researchers, healthcare professionals, and industry leaders from around the world, expanding your professional network.

6. Collaboration and Partnerships

Discover opportunities to collaborate and build partnerships that could lead to impactful research, clinical trials, and career growth in the field of gene therapy.

7. Embrace Technological Advancements

Gain insights into the latest technologies transforming gene therapy, including CRISPR, RNA therapies, and AI-driven gene therapy innovations.

8. Shape the Future of Medicine

Be part of discussions on the next generation of gene therapies for a wide range of conditions, helping to shape the future of medicine and patient care.

Who will Attend Gene Forum Conference?

  • Directors, CEOs of Organizations
  • Researchers and Scientists
  • Healthcare Professionals
  • Industry Professionals
  • Policy Makers and Government Officials
  • Non-Governmental Organizations (NGOs) and International Organizations
  • Students and Early Career Professionals
  • Investors and Financial Analysts
  • Media and Communication Professionals
  • Technology and Innovation Experts
  • Vice Presidents/Senior Vice Presidents/Executive Vice Presidents
  • Deans/Senior Professors/Associate Professor/Assistant Professors
  • Business Entrepreneurs
  • Medical Devices Manufacturing Companies
  • Vaccine Developers and Investigators

Highlighting Your Achievements

// Programs

Program Schedule

Will be upadated soon...





For regular updates bookmark gene therapy conferences website

[ X ]
Check-Out More About the conference. Download the Brochure Now!!